RA Capital Nexus Fund II, Director: Janux Therapeutics JANX Buy · Filed 24/10/22

Trade details

Type: Insider buy
Amount: $53,700,000
Shares · price: 1,200,000 sh · $44.75 a share
Held after: 9,317,246 sh
Stock: Janux Therapeutics JANX
Person: RA Capital Nexus Fund IIDirector
Trade date: 24/10/18
Filed: 24/10/22
Days to filing: 4 days

First buy in 1 years

Since the last buy: 1.3 years
Last buy: 23/07/19
Insiders buying this week: 5 insiders
Holding change: +14.8%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/18~24/11/17

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06